Abstract
The current standard of care for classical Hodgkin lymphoma (HL) is multiagent chemotherapy with or without radiation. In patients who relapse or fail to respond, additional high-dose chemotherapy with autologous hematopoietic stem cell transplantation (AHSCT) can improve progression-free survival (PFS). Novel therapies are required for patients refractory to chemotherapy and AHSCT. The mammalian target of rapamycin inhibitor everolimus has shown preliminary activity in preclinical models of HL and promising efficacy in patients with relapsed or refractory HL. This was an open-label, two-stage, phase 2 study that enrolled 57 patients aged ≥ 18 years with classic HL that had progressed after standard therapy. Patients received everolimus 10 mg daily until disease progression, intolerable toxicity, withdrawal of consent, or investigator decision. The primary endpoint was overall response rate; secondary endpoints included PFS, overall survival, time to response, duration of response, and safety. Overall response rate was 45.6% (95% confidence interval [CI] 32.4-59.3%); five patients (8.8%) experienced a complete response and 21 patients had a partial response (36.8%). Median PFS was 8.0 months (95% CI 5.1-11.0 months). Seven pati...Continue Reading
References
Mar 1, 1989·Controlled Clinical Trials·R Simon
Apr 24, 1993·Lancet·D C LinchG V Hudson
Jun 28, 2002·Lancet·Norbert SchmitzUNKNOWN Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Jul 15, 2003·Bone Marrow Transplantation·F Gutierrez-DelgadoW Bensinger
Oct 22, 2003·Archives of Medical Research·Guillermo J Ruiz-ArgüellesBenjamín López-Ariza
Feb 17, 2005·The Journal of Pathology·Amanda DuttonPaul G Murray
Mar 18, 2005·Leukemia·S NagelR A F MacLeod
May 12, 2005·Blood·Franziska JundtBernd Dörken
Sep 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Karen W L YeeFrancis J Giles
Oct 3, 2007·Hematology/oncology Clinics of North America·Bruce D Cheson
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Irene M GhobrialThomas E Witzig
Nov 5, 2010·The New England Journal of Medicine·Anas YounesAndres Forero-Torres
Jan 26, 2011·Blood·John KuruvillaMichael Crump
Apr 13, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Camillo PortaRobert J Motzer
Oct 20, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D A EichenauerUNKNOWN ESMO Guidelines Working Group
Mar 6, 2012·The Oncologist·Radhakrishnan Ramchandren
Mar 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anas YounesRobert Chen
Apr 6, 2012·The Korean Journal of Hematology·Erin-Siobhain R Currin, Ajay K Gopal
May 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anas YounesAndreas Engert
Apr 2, 2014·Transplantation Reviews·Bruce KaplanJason R Wellen
Jul 30, 2014·Clinical Breast Cancer·Denise A Yardley
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonT Andrew Lister
Dec 9, 2014·The New England Journal of Medicine·Stephen M AnsellPhilippe Armand
Dec 24, 2014·Blood·Ajay K GopalAnas Younes
Apr 19, 2015·Blood·Achim RotheAndreas Engert
Jan 27, 2017·Journal of Hematology & Oncology·Jun WangZihai Li
Dec 3, 2017·Journal of Hematology & Oncology·Bingshan LiuDelong Liu
Citations
Nov 9, 2018·British Journal of Haematology·Boris Böll, Helen Görgen
Dec 12, 2018·British Journal of Haematology·Gottfried von Keudell, Anas Younes
Apr 11, 2018·American Journal of Hematology·Stephen M Ansell
Aug 4, 2018·Der Nervenarzt·S KnaussM Endres
May 2, 2020·Cells·Burkitkan AkbaySvetlana Dokudovskaya
Jul 7, 2019·Journal of Hematology & Oncology·Hui HuaYangfu Jiang
Jun 20, 2019·Frontiers in Oncology·Stefania CrisciAntonio Pinto
Feb 8, 2019·British Journal of Haematology·Monika L Metzger, Christine Mauz-Körholz
Aug 12, 2018·International Journal of Molecular Sciences·Hannah E Walters, Lynne S Cox
Apr 3, 2019·Cancers·Alain Antoine MinaBarbara Pro
Feb 29, 2020·Therapeutic Advances in Hematology·Theodoros P VassilakopoulosMaria K Angelopoulou
Dec 7, 2019·Hematology·Reid W Merryman, Ann LaCasce
Dec 11, 2020·Hematological Oncology·Desheng KongYinghua Li
Jan 26, 2021·Frontiers in Oncology·Yimei FengXi Zhang
Oct 16, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Filip JankuMichelle A Fanale
Nov 15, 2021·British Journal of Haematology·Sarah GillessenBastian von Tresckow
Dec 11, 2021·Hematology·Narendranath Epperla, Mehdi Hamadani
Jan 18, 2022·Leukemia & Lymphoma·Karan Chohan, Stephen M Ansell